|
Feb 24
|
Cathie Wood buys $11 million of under-the-radar AI stock
|
|
Feb 24
|
Beam Therapeutics to Participate in Upcoming March 2025 Investor Conferences
|
|
Feb 23
|
Why Beam Therapeutics Inc. (BEAM) is the Best Performing Pharma Stock So Far in 2025
|
|
Feb 21
|
Apellis Pharmaceuticals, Inc. (APLS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|
|
Feb 13
|
Wall Street Analysts See a 67.27% Upside in Beam Therapeutics (BEAM): Can the Stock Really Move This High?
|
|
Feb 10
|
Is Beam Therapeutics (BEAM) Outperforming Other Medical Stocks This Year?
|
|
Dec 30
|
Why Is Beam Therapeutics Inc. (BEAM) Among the Top CRISPR Stocks to Invest In?
|
|
Dec 29
|
Beam Therapeutics Inc. (BEAM): Is This Gene Therapy Stock a Good Buy Right Now?
|
|
Jul 26
|
Beam Therapeutics (BEAM) Soars 7.9%: Is Further Upside Left in the Stock?
|
|
Jul 24
|
Beam Therapeutics Stock Earns RS Rating Jump To 85
|
|
Jul 24
|
CRISPR Therapeutics Nears 52-Week Low. Time to Buy?
|
|
Jul 22
|
3 Gene Editing Stocks Shaping the Future of Medicine
|
|
Jun 14
|
Beam Therapeutics Reports Data Highlighting Optimized Manufacturing Process for BEAM-101, an Investigational Base Editing Therapeutic for Sickle Cell Disease
|
|
May 14
|
Beam Therapeutics to Present Data Highlighting Robust Manufacturing Process for BEAM-101 at 2024 European Hematology Association (EHA) Hybrid Congress
|
|
May 13
|
15 Best ARK Stocks To Buy Now
|
|
May 9
|
Biotech Breakthroughs: 3 Stocks on the Verge of Revolutionizing Medicine
|
|
May 9
|
Beam Therapeutics Inc. (NASDAQ:BEAM) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
|
|
May 8
|
Beam Therapeutics (BEAM) Q1 Loss Narrows, Revenues Miss
|
|
May 8
|
Beam Therapeutics to Participate in RBC Capital Markets 2024 Global Healthcare Conference
|
|
May 8
|
Beam Therapeutics Inc (BEAM) Reports Q1 2024 Earnings: A Detailed Overview
|